LGND - Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q4 2018 Results - Earnings Call Transcript
Ligand Pharmaceuticals Incorporated (LGND)
Q4 2018 Results Earnings Conference Call
February 07, 2019, 04:30 PM ET
Company Participants
Todd Pettingill - Director, Corporate Development and Investor Relations
John Higgins - Chief Executive Officer
Matthew Foehr - President and Chief Operating Officer
Matthew Korenberg - Executive Vice President, Finance and Chief Financial Officer
Conference Call Participants
Joe Pantginis - H.C. Wainwright
Matt Hewitt - Craig-Hallum Capital
Larry Solow - CJS Securities
Dana Flanders - Goldman Sachs
Scott Henry - Roth Capital
Presentation
Operator
Good afternoon. And welcome to the Ligand Fourth Quarter Earnings Call. My name